IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer

This report highlights a potential new approach to enhancing the chemotherapeutic potential of NSCLC-treating cisplatin.PMID:38396325 | PMC:PMC10891307 | DOI:10.1111/jcmm.18185
Source: J Cell Mol Med - Category: Molecular Biology Authors: Source Type: research